Medtronic shares surge; diabetes unit has best sales growth in 10+ years

Sales of the company’s MiniMed 670G device, which is the med-tech giant's latest “artificial pancreas” system, partly drove the diabetes division's strong performance.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.